Advances in HTLV-1 Peptide Vaccines and Therapeutics

Publisher： Bentham Science Publishers

E-ISSN： 1875-5550|7|2|137-145

ISSN： 1389-2037

Source： Current Protein and Peptide Science, Vol.7, Iss.2, 2006-04, pp. : 137-145

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Synthetic peptide vaccines

By Moisa A.   Kolesanova E.  

Biochemistry (Moscow) Supplement Series B: Biomedical Chemistry, Vol. 4, Iss. 4, 2010-12 ,pp. : 321-332

MAIK Nauka/Interperiodica

Access to resources Recommend Favorite

Advances in pain therapeutics

By LoGrasso P.   McKelvy J.  

Current Opinion in Chemical Biology, Vol. 7, Iss. 4, 2003-08 ,pp. : 452-456

Elsevier

Access to resources Recommend Favorite

Recent advances in vaccines for leishmaniasis

By Requena Jose M   Iborra Salvador   Carrión Javier   Alonso Carlos   Soto Manuel  

Expert Opinion on Biological Therapy, Vol. 4, Iss. 9, 2004-09 ,pp. : 1505-1517

Informa Healthcare

Access to resources Recommend Favorite

Peptide-based vaccines for cancer immunotherapy

By Brinkman Joeli A   Fausch Steven C   Weber Jeffrey S   Kast W Martin  

Expert Opinion on Biological Therapy, Vol. 4, Iss. 2, 2004-02 ,pp. : 181-198

Informa Healthcare

Access to resources Recommend Favorite

Integration of HTLV-1 Provirus into Mouse Transforming Growth Factor-alpha Gene

By Fang J.   Kushida S.   Feng R.   Tanaka M.   Kikukawa H.   Kawamura T.   Uchida K.   Miwa M.  

Biochemical and Biophysical Research Communications, Vol. 233, Iss. 3, 1997-04 ,pp. : 792-795

Elsevier

Access to resources Recommend Favorite